Literature DB >> 30302216

Updated classification and novel treatment prospective for nodal peripheral T-cell lymphomas.

Pier Paolo Piccaluga1,2,1,2.   

Abstract

Entities:  

Keywords:  classification; molecular biology; new drugs; peripheral T-cell lymphoma; stem cells transplantation; targeted therapy

Year:  2017        PMID： 30302216      PMCID： PMC6171976          DOI： 10.2217/ijh-2017-0006

Source DB:  PubMed          Journal:  Int J Hematol Oncol        ISSN： 2045-1393


× No keyword cloud information.
  20 in total

1.  Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Authors:  Bertrand Coiffier; Barbara Pro; H Miles Prince; Francine Foss; Lubomir Sokol; Matthew Greenwood; Dolores Caballero; Peter Borchmann; Franck Morschhauser; Martin Wilhelm; Lauren Pinter-Brown; Swaminathan Padmanabhan; Andrei Shustov; Jean Nichols; Susan Carroll; John Balser; Barbara Balser; Steven Horwitz
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

Review 2.  Current state of art for transplantation paradigms in peripheral T-cell lymphomas.

Authors:  Giulia Perrone; Lucia Farina; Paolo Corradini
Journal:  Expert Rev Hematol       Date:  2013-08       Impact factor: 2.929

Review 3.  Peripheral T-cell lymphoma classification: the matter of cellular derivation.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Claudio Tripodo; Anna Gazzola; Francesco Bacci; Elena Sabattini; Stefano A Pileri
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

4.  NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

Authors:  Steven M Horwitz; Andrew D Zelenetz; Leo I Gordon; William G Wierda; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; Nancy Bartlett; John C Byrd; Luis E Fayad; Richard I Fisher; Martha J Glenn; Thomas M Habermann; Nancy Lee Harris; Francisco Hernandez-Ilizaliturri; Richard T Hoppe; Mark S Kaminski; Christopher R Kelsey; Youn H Kim; Susan Krivacic; Ann S LaCasce; Matthew Lunning; Auayporn Nademanee; Oliver Press; Rachel Rabinovitch; Nishitha Reddy; Erin Reid; Kenneth Roberts; Ayman A Saad; Lubomir Sokol; Lode J Swinnen; Julie M Vose; Joachim Yahalom; Nadeem Zafar; Mary Dwyer; Hema Sundar; Pierluigi Porcu
Journal:  J Natl Compr Canc Netw       Date:  2016-09       Impact factor: 11.908

5.  Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

Authors:  Owen A O'Connor; Steven Horwitz; Tamás Masszi; Achiel Van Hoof; Peter Brown; Jeannette Doorduijn; Georg Hess; Wojciech Jurczak; Poul Knoblauch; Shanta Chawla; Gajanan Bhat; Mi Rim Choi; Jan Walewski; Kerry Savage; Francine Foss; Lee F Allen; Andrei Shustov
Journal:  J Clin Oncol       Date:  2015-06-22       Impact factor: 44.544

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

7.  Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.

Authors:  Owen A O'Connor; Barbara Pro; Lauren Pinter-Brown; Nancy Bartlett; Leslie Popplewell; Bertrand Coiffier; Mary Jo Lechowicz; Kerry J Savage; Andrei R Shustov; Christian Gisselbrecht; Eric Jacobsen; Pier Luigi Zinzani; Richard Furman; Andre Goy; Corinne Haioun; Michael Crump; Jasmine M Zain; Eric Hsi; Adam Boyd; Steven Horwitz
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

Review 8.  Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas.

Authors:  Pier Luigi Zinzani; Vijayveer Bonthapally; Dirk Huebner; Richard Lutes; Andy Chi; Stefano Pileri
Journal:  Crit Rev Oncol Hematol       Date:  2016-01-03       Impact factor: 6.312

9.  Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

Authors:  Francesco d'Amore; Thomas Relander; Grete F Lauritzsen; Esa Jantunen; Hans Hagberg; Harald Anderson; Harald Holte; Anders Österborg; Mats Merup; Peter Brown; Outi Kuittinen; Martin Erlanson; Bjørn Østenstad; Unn-Merete Fagerli; Ole V Gadeberg; Christer Sundström; Jan Delabie; Elisabeth Ralfkiaer; Martine Vornanen; Helle E Toldbod
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

10.  Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.

Authors:  J H Schatz; S M Horwitz; J Teruya-Feldstein; M A Lunning; A Viale; K Huberman; N D Socci; N Lailler; A Heguy; I Dolgalev; J C Migliacci; M Pirun; M L Palomba; D M Weinstock; H-G Wendel
Journal:  Leukemia       Date:  2014-09-03       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.